For VC & PE Funds
Identify hidden risk concentration across your medtech portfolio before it impacts returns.
How It Works
Submit 3-5 portfolio companies. Our team analyzes each against our proprietary risk framework, then identifies risk concentration patterns across your entire portfolio.
Detailed assessment of each portfolio company with proprietary scoring and pattern analysis.
Identify if your portfolio is overexposed to specific regulatory pathways, reimbursement models, or technical risks.
See how your portfolio companies compare to similar devices in our documented success and failure database.
Highlighted risks that, if unaddressed, could lead to common failure patterns we've documented.
Sample Output
A redacted example from a retrospective portfolio analysis. Each cell shows the Vantage Score for that category.
| Company | Regulatory | Clinical | Reimbursement | IP & Tech | Commercial | Vantage Score |
|---|---|---|---|---|---|---|
| Company A Orthopedic implant |
Low | Low | Med | Low | Med | Pass |
| Company B Digital therapeutic |
Med | High | High | Low | High | Flag |
| Company C Surgical robotics |
Low | Low | Low | Med | Low | Pass |
| Company D Wearable diagnostic |
Med | Med | High | Low | Med | Conditional |
| Company E Point-of-care Dx |
Low | Low | Low | Med | Low | Pass |
Multiple portfolio companies score below threshold on Reimbursement — indicating systemic underinvestment in payer strategy. If reimbursement headwinds intensify, a significant portion of portfolio value is exposed simultaneously. Recommended: Prioritize payer engagement for Companies B, D, and conduct reimbursement stress test across portfolio.
Deliverables
15–25 page report with per-company Vantage Scores, domain breakdowns, and cross-portfolio pattern analysis. IC-ready format.
Visual concentration map showing exactly where risk clusters across your portfolio — by category, by domain, by company.
Each company mapped against similar devices from our outcome database. See who your companies most closely resemble.
Ranked intervention recommendations per company. Specific, actionable steps to reduce your portfolio's highest-impact risks.
Pricing & Availability
Complimentary for qualified VC/PE funds
Get a high-level risk profile of your portfolio with pattern summary. Ideal for understanding where your portfolio sits on the risk spectrum.
Deep-dive risk analysis
Comprehensive assessment with company-by-company breakdowns, concentration analysis, and strategic recommendations. View detailed pricing →
Let's start with a free conversation about your portfolio and what patterns we're seeing in your category.